INIS
recommendations
100%
arthritis
100%
patients
37%
latin america
25%
evaluation
25%
assessments
25%
diseases
25%
tools
12%
information
12%
interventions
12%
values
12%
implementation
12%
decision making
12%
management
12%
resources
12%
guidelines
12%
optimization
12%
drugs
12%
therapy
12%
failures
12%
panels
12%
mortality
12%
damage
12%
quality of life
12%
corticosteroids
12%
Medicine and Dentistry
Rheumatology
100%
Psoriatic Arthritis
100%
Biological Product
16%
Decision Making
16%
Quality of Life
16%
Chronic Disease
16%
Antiinflammatory Agent
16%
Disease Modifying Antirheumatic Drug
16%
Functional Limitation
16%
Corticosteroid Therapy
16%
Biological Therapy
16%
Nursing and Health Professions
Psoriatic Arthritis
100%
Rheumatologist
33%
Clinical Practice
16%
Practice Guideline
16%
Quality of Life
16%
Chronic Disease
16%
Disease Modifying Antirheumatic Drug
16%
Biological Product
16%
Biological Therapy
16%
Antiinflammatory Agent
16%
Corticosteroid Therapy
16%
Pharmacology, Toxicology and Pharmaceutical Science
Psoriatic Arthritis
100%
Biological Product
16%
Chronic Disease
16%
Antiinflammatory Agent
16%
Disease Modifying Antirheumatic Drug
16%